Nationwide Fund Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-23,765
| Closed | -$467K | – | 73 |
|
|
2017
Q3 | $467K | Buy |
23,765
+2,362
| +11% | +$46.4K | ﹤0.01% | 2219 |
|
|
2017
Q2 | $308K | Buy |
21,403
+915
| +4% | +$13.2K | ﹤0.01% | 2435 |
|
|
2017
Q1 | $188K | Sell |
20,488
-2,937
| -13% | -$27K | ﹤0.01% | 2618 |
|
|
2016
Q4 | $244K | Buy |
23,425
+1,429
| +6% | +$14.9K | ﹤0.01% | 2516 |
|
|
2016
Q3 | $199K | Buy |
21,996
+1,059
| +5% | +$9.58K | ﹤0.01% | 2623 |
|
|
2016
Q2 | $157K | Hold |
20,937
| – | – | ﹤0.01% | 2724 |
|
|
2016
Q1 | $189K | Buy |
20,937
+5,013
| +31% | +$45.3K | ﹤0.01% | 2557 |
|
|
2015
Q4 | $206K | Buy |
15,924
+474
| +3% | +$6.13K | ﹤0.01% | 2537 |
|
|
2015
Q3 | $149K | Hold |
15,450
| – | – | ﹤0.01% | 2719 |
|
|
2015
Q2 | $159K | Buy |
15,450
+9,870
| +177% | +$102K | ﹤0.01% | 2824 |
|
|
2015
Q1 | $62K | Sell |
5,580
-28,706
| -84% | -$319K | ﹤0.01% | 3063 |
|
|
2014
Q4 | $399K | Buy |
34,286
+28,312
| +474% | +$329K | ﹤0.01% | 2316 |
|
|
2014
Q3 | $132K | Buy |
5,974
+3
| +0.1% | +$66 | ﹤0.01% | 2885 |
|
|
2014
Q2 | $166K | Buy |
+5,971
| New | +$166K | ﹤0.01% | 2838 |
|